Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.05
+0.03 (0.43%)
At close: Sep 12, 2025, 4:00 PM EDT
7.07
+0.02 (0.28%)
After-hours: Sep 12, 2025, 4:10 PM EDT
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $490.00 million as of September 12, 2025. Its market cap has decreased by -68.52% in one year.
Market Cap
490.00M
Enterprise Value
-224.26M
1-Year Change
-68.52%
Ranking
Category
Stock Price
$7.05
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $490.00M, an increase of 130.74%. That is a compound annual growth rate of 14.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 486.53M | -49.67% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | 382.42M | 126.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |